Precision medicine against metastatic prostate cancer: proposed actions to reverse current challenges
Barcelona, November 26, 2020.- Despite recent progress in [...]
Recognized by their peers, applauded by the world: VHIO’s Josep Tabernero and Enriqueta Felip among Clarivate’s 6,167 Global Highly Cited Researchers 2020
Barcelona, November 18th, 2020.- Published today, Clarivate’s Web [...]
Strengthening cancer control & prevention: ESMO and IACR co-launch the World Cancer Report’s e-learning platform
Launching this coming Thursday 19 November, the [...]
Countdown to World Cancer Day 04 February: the 21 Days to Impact Challenge
February 04, 2021 will not only celebrate [...]
Movember movement against prostate cancer: much more than moustaches
Movember, celebrated globally throughout the month of [...]
VHIO in 2019: tick tock toward 2025
The number 25 is the focus of [...]
Cerebrospinal fluid as liquid biopsy for the precise characterization and policing of medulloblastoma
Results from a proof-of-concept study led by [...]
A new medication for acute myeloid leukaemia shows positive results in a first-in-human clinical trial
Vall d’Hebron has participated in the first [...]
Immune-based therapy promises a new therapeutic avenue for patients with advanced or recurrent endometrial cancer
Preliminary results from the multicenter, nonrandomized GARNET [...]
Immunotherapy gains ground as an alternative for cancer treatment
For the first time, an immunotherapy treatment [...]